November 17, 2026
Business

Biocon eyes in-licensing deals to expand biosimilars portfolio in FY27(Soban News)

Biocon is scouting for biosimilar in-licensing opportunities while banking on multiple FY27 product launches to drive growth, margins, and market expansion

​Biocon is scouting for biosimilar in-licensing opportunities while banking on multiple FY27 product launches to drive growth, margins, and market expansion by Soban News (international And National News)

Related posts

Capgemini seeks CCI approval to acquire Singapore-based Cloud4C firm

News-Soban-Admin

Cybersecurity infra worth $1 trillion isn’t ready for AI; Palo Alto CEO says tech is forcing companies to modernise(Soban News)

News-Soban-Admin

Call centre duping Australian citizens busted in Madhapur, 9 held – Siasat.com(Soban News)

News-Soban-Admin

Leave a Comment